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Abstract
This report describes a technique for the generation of transgenic mice by in vivo manipulation of spermatogonial stem
cells with a high rate of success. Spermatogonial stem cells (SSCs) in pre-pubescent animals were infected in vivo with
recombinant lentiviruses expressing EGFP-f and mated with normal females. All male pre-founder mice produced transgenic
pups with an overall success rate of over 60%. The transgene was heritable and the pre-founder mice could be used in
multiple mating experiments. This technology could be used to perform overexpression/knockdown screens in vivo using
bar-coded lentiviruses, thus permitting the design of genetic screens in the mouse. Further, this technology could be
adapted to other laboratory animals resulting in the generation of model systems that closely approximate human
development and disease.
Citation: Sehgal L, Thorat R, Khapare N, Mukhopadhaya A, Sawant M, et al. (2011) Lentiviral Mediated Transgenesis by In Vivo Manipulation of Spermatogonial
Stem Cells. PLoS ONE 6(7): e21975. doi:10.1371/journal.pone.0021975
Editor: David S. Milstone, Brigham and Women’s Hospital, United States of America
Received March 6, 2011; Accepted June 14, 2011; Published July 7, 2011
Copyright:  2011 Sehgal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by the Department of Biotechnology grants BT/PR6521/Med/14/828/2005 and BT/PR12578/MED/31/75/2009, Advanced Centre
for Treatment Research and Education in Cancer (ACTREC) core funds to SND, and a UGC fellowship for AM. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sdalal@actrec.gov.in
Introduction
The generation of genetically modified mice has spurred great
advances in our understanding of various aspects of growth and
development. Multiple technologies have used either injection into
a one celled embryo followed by implantation into a pseudo
pregnant mother [1], or used stem cell aggregation techniques to
generate either knockout [2] or knockdown mice [3]. These
experiments are expensive, labor-intensive, time-consuming and
require several female donors.
Spermatogonial stem cells are responsible for the production of
spermatozoa [4] and are an appropriate target for germline
modification [5]. Nagano et al. have generated transgenic mice by
infecting spermatogonial stem cells in vitro with recombinant
retroviruses followed by xenogenic transplantation of the cells into
the testes of a male mouse [6]. In some cases the recipient mice
were unreceptive to the donor spermatogonial cells [6] and the
overall success rate was rather low. Similarly, in vivo transduction of
testicular germ cells with retroviral constructs carrying a lacZ
gene, resulted in a poor success rate of 2.8% [7]. The low success
rates post implantation, however precluded these from replacing
embryonic injection. Similar experiments using lentiviruses,
resulted in better success rates [8]. Other methods employed in
the recent past have infected fertilized eggs in vitro with
recombinant lentiviruses, followed by implantation of the embryo
into pseudopregnant females [9]. While these methods provided
better success rates, the implantation experiments are technically
cumbersome and require several female donors. A recent report
has also described the generation of recombinant spermatozoa in
organotypic cultures that could be used to generate transgenic
mice [10]. While this method generated transgenic animals at high
efficiency, generating organotypic cultures is not trivial and is not
performed in most laboratories. Recently, a report has described
the generation of transgenic mice after electroporation of DNA
into the testes of an adult mouse. 16 of 17 fore founder mice
generated in that study were able to sire transgenic pups.
However, the report did not mention the rate of transgenesis in
the pups [11].
This report describes a new cost effective, faster technique with
a high success rate for generation of transgenic mice by in vivo
viral transduction of the EGFP-f transgene into undifferentiated
spermatogonia. These fore-founder male mice were mated with
wild type female mice to generate transgenic pups. The rate of
transgenesis was greater than 60% and the transgene was inherited
in the germ line. This rapid protocol for the generation of
transgenic mice could be used to design and perform over-
expressor/knockdown screens in the whole animal, thus enhanc-
ing our knowledge of disease and development.
Results
Recombinant lentiviruses expressing EGFP-f (EGFP tagged
with a farnesylation signal) were injected into the intertubular
spaces of the testis targeting undifferentiated spermatogonia pre-
sent in the seminiferous tubules. Injection into the intertubular
space allows the lentivirus to infect undifferentiated spermatogo-
nial cells located at the basement of the seminiferous tubules [12].
Previous results had indicated that a lentivirus vector in which
cDNA’s were downstream of the CMV promoter was not effective
in achieving lentiviral transduction and expression in germ line
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elongation factor1a (EF1-a) promoter driving the expression of
EGFP-f, followed by SV40 poly-adenylation sequence was
assembled in pBSK. The assembled cassette was further sub
cloned in pLKO.1 [14] to generate a vector that could express
both EGFP-f and an shRNA downstream of the U6 promoter
(Figure 1A).
5–10 ml of recombinant EGFP-f expressing lentiviruses (5610
6
TU/ml) was injected into the intertubular spaces of the testis of 28
day old Crl:CFW(SW) male mice (Figure 1B). These male mice,
referred to as pre-founder mice, were mated with wild type females
of the same strain 35 days post infection. To determine whether the
progenyfromthiscrosscarried thetransgene,EGFP-fwas amplified
from genomic DNA isolated from the progeny. An amplification for
the patch gene served as a loading control (Figure 1C–E).
Transgenic pups were generated from mating experiments with
three independently derived pre-founder mice at an overall rate
greater than 60% (Figure 1C–E, Table 1),a rate that is much higher
than previously reported with conventional transgenic protocols or
with retroviral infection of spermatogonial stem cells in vitro or in vivo
[6,7]. All mice showed amplification for the patch gene, which
served as a loading control and also demonstrated that the band for
EGFP-f was specific. Further, WT mice did not show any product
for the EGFP-f transgene (data not shown). Inbreeding of transgene
positive pups from the mice showed an increased incidence of
transgene positivity in the F1 generation and an even higher
incidence in the F2 generation (Figure 1C). Further, a transgene
positive male mouse, 1883, was out bred with a wild type female
mouse of the same strain. Three of the six pups from this cross
showed the presence of the transgene (Figure 1C). These results
suggest that inheritance of the transgene is stable and that fertility of
the transgenic mice is not compromised.
To determine whether the transgene was expressed in multiple
tissues, tissues from organs of an F1 GFP positive mouse and a
GFP negative litter mate were analyzed for the presence of the
EGFP-f transgene by Reverse Transcriptase PCR (RT-PCR) and
fluorescence microscopy. As shown in Figure 2A, the EGFP-f
transgene positive animal showed the presence of the EGFP-f
message as compared to RNA prepared from tissue sections
derived from the negative litter mate control. A RT-PCR analysis
for the housekeeping gene, GAPDH, served as a loading control.
Similarly, tissue sections from the transgenic mice showed green
Figure 1. Generation of transgenic mice. A. Design of the vector used for generating transgenic mice. B. Injection of recombinant lentiviruses
into mouse testis. C–E. Pedigree analysis for pre-founder mice 607 (c), 608 (d) and 609 (e) showing germline transmission of the transgene. Individual
mice were assigned numbers for further experiments. Genomic DNA amplification using primers for EGFP-f or patch (as a loading control) are shown.
doi:10.1371/journal.pone.0021975.g001
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mice (Figure 2B). An analysis of hematoxylin and eosin stained
sections of different tissues indicate no change in the morphology
of tissue from transgenic mice as compared to control mice
(Figure 2C). The mean intensity fluorescence obtained by three
different section of the same tissue of transgenic mice is much
higher when compared to control mice (Figure 2D).
To demonstrate that the spermatogonial stem cells had been
infected in the pre-founder mice, the mice were sacrificed after
multiple breeding experiments and tissue sections prepared from
the testis of the pre-founder and control mice. The tissue sections
were stained with antibodies to GFP. As shown in Figure 2E, cells
in the interstitial spaces and the spermatogonial stem cells showed
staining for GFP in pre-founder but not in control mice. An
immunofluoresence analysis on sections from the epididymis
followed by confocal microscopy demonstrated that mature sperm
also stained positively for GFP in profounder mice, whereas
sections from wild type mice did not show any signal for GFP
(Figure 2F). The GFP staining mostly localized to the tail region
and was mostly excluded from the head region.
The pre-founder mice were able to sire transgenic pups for over
a year after infection with the recombinant lentivirus indicating
that the transgene was integrated in the spermatogonial cells. To
demonstrate that expression of the transgene was independent of
the site of integration, integration sites were mapped in founder
mice using a variant of a protocol developed by Schroder et al.
[15] as summarized in Figure 3A. The integration events to
different sites on chromosomes were represented graphically as
described earlier [16]. In addition, we have listed the percentage of
total integration events on each chromosome in Figure 3B. Most of
the integration events were observed in three different sites on
chromosome two. This resulted in the maximum number of mice
having integrants in chromosome two. The sites of integration
were sequenced and the distribution among the different
chromosomes mapped as shown in Figure 3B and Table 2. These
results show that expression of the transgene was independent of
the site of integration. Further, the number of integration events in
each transgenic mouse was determined. It was observed that most
mice had either one or two integration events (Figure 3C). The
percentage of mice having either one, two or three integration
events is also listed in Figure 3C. This suggests that at the virus
titer used in these experiments most spermatogonial stem cells
develop either one or two integration events.
Discussion
The experiments in this report describe the development of a
simple, cost effective, and efficient technique for the generation of
transgenic mice by in vivo transduction of the desired gene/shRNA
construct into undifferentiated spermatogonia of the testis. This
technology does not compromise the fertility of the off-spring,
resulting in germline transmission of the transgene, using a limited
number of animals.
Previously published reports have demonstrated that lentiviral
mediated transgenesis results is relatively stable and can be
inherited in the germline [9,17,18,19]. Thus, the use of lentiviruses
as a vector delivery system to generate transgenic animals does not
compromise inheritance or the development of the animal, results
that are consistent with those obtained in this report. Further,
previous protocols that modify spermatogonial stem cells, either in
vitro or in vivo, used retroviruses and yielded transgenic pups at
very low efficiencies [6,7]. Previously, male rat germ cells were
transduced in culture using HIV-1 based lentiviral vectors, which
were then transplanted into the testis of wild type rats [8]. The rate
of colonization of the recombinant germ cells in wild type testis
was low (33%) and only one of three male mice was fertile. The
founder mice in these experiments produced founder pups at a
rate of 30% [8]. The processes reported in this paper result in a
very high rate of transgenesis, with all the animals being able to
sire transgenic pups, leading to the rapid generation of multiple
transgenic pups with different integration events allowing the
generation of multiple transgenic lines.
Recently, organotypic testis cultures have been generated that
allow the production of recombinant sperm, which could be used to
generatetransgenicanimals[10].Whilethisallowsthegenerationof
recombinant sperm without the generation of profounder animals,
the process can be technically challenging, especially for laborato-
ries not used to establishing and propagating organotypic cultures.
The procedures described in this report are easily performed and
require a small simple surgery. Although, the rate of transgenesis
reported here may not be better than the conventional lentiviral
transgenesis method [9], the technique is cost effective, simple and
faster to perform. Further, infecting the spermatogonial stem cells in
vivo allows the repeated use of the pre-founder, eliminating the
necessity to repeatedly infect embryos or organotypic cultures with
lentiviruses. Further, as demonstrated here the pre-founder mice
canbematedmultipletimes,resultingthegenerationofanumberof
transgenic pups. As multiple transgenic lines are required to rule out
integration site specific events, the generation of multiple lines
described herein results in a quick analysis of the phenotype and
allows experiments to proceed at a rapid pace.
Several groups have reported that knockdown mice replicate the
phenotypes observed in knockout mice [3,20,21]. While this
greatly enhances the ability of scientists to study the consequences
of gene depletion in the whole animal, the use of implantation
strategies did not permit the use of genetic screens using lentivirus
driven bar-coded shRNA’s, as performed in cell lines in culture
Table 1. Percentage of EGFP-f positive pups obtained from
individual matings with three different pre-founder mice.
Pre-founder
mice
Founder Mice
per litter
Founder mice per litter
positive for EGFP-f
607 8 1
607 11 9
607 6 4
Total 25 14
Success rate 56%
608 8 5
608 6 4
608 8 4
Total 22 13
Success rate 59%
609 8 4
609 12 10
609 13 7
Total 33 22
Success rate 66%
Grand Total 80 49
Total success rate 61.25%
The pre-founder mice were mated with multiple WT female mice and the
frequency of EGFP-f positive pups determined after each mating. Note that an
overall success rate of greater than 60% was obtained in these matings.
doi:10.1371/journal.pone.0021975.t001
Transgenesis Using Spermatogonial Stem Cells
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21975Figure 2. EGFP-f expression in various tissues of founder mice. A. Multiple tissue sections from control and transgenic littermates were
analyzed for the expression of EGFP-f mRNA by RT-PCR analysis. Control mice did not show the presence of the EGFP-f mRNA but transgenic mice
showed the expression of the EGFP-f mRNA in multiple tissues (H=heart, B=brain, L=liver, Lu=lung and S=skin). An RT-PCR was performed for
GAPDH as a loading control. B. Multiple tissue sections from control and transgenic littermates were analyzed for the expression of the EGFP-f
transgene by confocal microscopy. Original magnification is 6306. Scale bars are shown in the figures. C. Hematoxylin and eosin stained sections
from wild type or transgenic mice. Original magnification is 6306. Scale bars are shown in the figures. D. The mean fluorescence intensity from
control and transgenic sections is on the Y-axis and the different tissues are represented on the X-axis. The error bars represent the standard
deviation for sections derived from at least three different mice. E. Testis sections from control mice or pre-founder mice were stained with antibodies
to GFP followed by immunflourescence analysis and confocal microcospy. The top panel shows the DIC image of the fluorescence field. Note that the
pre-founder mice show high levels of EGFP-f expression in both cells in the interstitial spaces and in spermatogonial stem cells (filled arrow) that line
the basement membrane of the seminiferous tubules. Original magnification is 6306and scale bars are indicated in the figures. ST=seminiferous
tubule and IS=interstitial spaces. F. Epididymis sections from control mice or pre-founder mice were stained with antibodies to GFP (green) and
propidium iodide (red) to stain DNA, followed by immunflourescence analysis and confocal microcospy. The top panel shows the DIC image of the
fluorescence field and the bottom panel shows the merged image. Note that the pre-founder mice show high levels of EGFP-f expression in the
sperm tails in the profounder mouse but not in WT mice. Original magnification is 6306and scale bars are indicated in the figures.
doi:10.1371/journal.pone.0021975.g002
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of such genetic screens in the whole animal to understand the
contribution of various gene products to growth, development and
disease. Screens using tissue specific production of miRNAs [24],
or by using either temporal or tissue specific Cre based inducible
systems [20,21] can also be designed to examine the effects of
knockdown/overexpression of a gene product in a particular tissue
type. As the experiments described in this report have shown, most
of the mice have one or two integration events. Therefore, it
should be possible to design genetic screens without worrying
about the complications that could ensue from multiple integration
events in the same animal. The number of integration events could
be increased or decreased by altering the titer of the virus used for
injection; however, lowering titer might hamper efficiency of
generation of transgenic mice in the F1 generation. The design of
the construct used in this report also permits that an in vivo rescue
experiment could be performed using one lentiviral construct that
expresses both the shRNA and the resistant cDNA from different
promoters, thus eliminating concern about off target effects of the
shRNA construct. Finally, the procedure could be extended to
other animals, especially non-human primates, resulting in a
significant advancement in transgenic research and the use of
models that are closer to human subjects to model human disease.
Materials and Methods
Animals
Swiss mice Crl:CFW(SW) were bred and maintained in the
laboratory animal facility of ACTREC. Maintenance of the
Figure 3. Analysis of integration events in the EGFP-f transgenic mice. A. Protocol for the identification of integration sites. B. Graph
showing the frequency of integration events observed in the transgenic animals. Chromosome number is on the X-axis and the number of mice
showing integration in the respective chromosomes is on the Y-axis. The number above each bar in the graph indicates the percentage of total
integration events analyzed on each chromosome. C. Graph showing the number of integration events in each mouse. No of integration events is on
the X-axis and number of mice on the Y-axis. The number above each bar indicates the percentage of mice with one, two or three integration events.
doi:10.1371/journal.pone.0021975.g003
Table 2. Summary of the integration events observed in the
different transgenic animals.
Chromosome
number
Accession
Number
Number of
mice showing
integrations
Identity of
mice showing
integrations
1 NT_39170.7 3 6 &,12
2 NW_001030712.1
NW_001030694.1
NW_001030686.1
9 11,12,33,35,45
&51
3 NT_039207
NT_162143
23 8
4 NW_001030747 2 49 & 54
6 NW_039353 1 33
8 NT_078575.6 3 11 & 45
13 NT_039578 2 6 & 38
14 NW001030543 2 42 & 37
18 NW_001030631
NW_001030635.1
31 2 & 5 2
The chromosome number is shown in column one while the number of the
individual mice with an integration in these chromosomes is shown in column
4. The integration events in each chromosome are shown in the third column of
this table with the appropriate accession number in column 2. As can be seen
from the table, multiple mice show different combinations of integration events
suggesting that transgene expression is independent of integration site. The
number of assigned to the mice in this table is similar to the number reported
in Figure 1.
doi:10.1371/journal.pone.0021975.t002
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Committee for the Purpose of Control and Supervision of the
Experiments on Animals (CPCSEA), Ministry of Environment and
Forest, Government of India. The animals were housed in a
controlled environment with the temperature and relative humi-
dity being maintained at 2362uC and 40–70% respectively and a
day night cycle of 12 hrs each (7:00 to 19:00 light; 19:00 to 7:00
dark). The animals were received an autoclaved balanced diet
prepared in-house as per the standard formula and sterile water ad
libitum. Mice were housed in the Individually Ventilated Cage
(IVC) system (M/S Citizen, India) provided with autoclaved rice
husk bedding material available locally. Protocols for the
experiments were approved by the Institutional Animal Ethics
Committee (IAEC) of ACTREC. The animal study proposal
number is 11/2008 dated August 19, 2008.
Generation of Lentiviral vectors
The EGFP-f (Farnesylated EGFP) expression cassette was
assembled in pBSK(-) (Stratagene). The sequences of all the
oligonucleotides used for gene amplification are shown in Table 3.
The EF1a promoter was amplified from pEF6MycHisA (Invitro-
gen) and cloned in pBSK digested with HindIII and EcoRI (NEB).
Subsequently, the EGFP-f gene was amplified and cloned
downstream of the EF1a promoter as a EcoRI and BamHI
fragment. The resulting vector was digested with BamHI and NotI
and the SV-40 Poly A signal, amplified from pEF6MycHisA, was
inserted using these restriction sites. A restriction site for BsuI5I
(Fermentas) was introduced upstream of the NotI restriction site.
The EGFP-F expression cassette was excised from pBSK (-) vector
with BsuI5I and cloned in pLKO.1 to generate pLKO.1 EGFP-f.
Virus Production
The lentiviral vector pLKO.1 EGFP-f was co-transfected with
the Vira Power packaging mix into 293-T cells and viruses were
harvested as per the manufacturers instructions (Invitrogen). The
lentiviruses were concentrated by centrifuging the tissue culture
supernatant at 350006g in a swinging bucket rotor for 45 minutes
at 4uC. The viral pellet was then dissolved in 1/100
th volume of
Dulbeco’s PBS (Invitrogen). The viral titre was determined using
flow cytometry for EGFP-f as per the manufacturers protocol
(Invitrogen).
Injection of viral particles and generation of transgenic
mice
28 day old Crl:CFW(SW) male mice were anesthetized by intra-
peritoneal injection of Avertin (Sigma) (2,2 tribromo-ethanol and
t-amyl alcohol at the rate of 0.015 ml/gm body weight). Hair was
removed from the inguinal area of mice and the surgical site was
cleaned using betadiene. Anterior to the penis, a single midline
cutaneous incision of approx. 1–1.5 cm length was made using
sterile surgical scissors under aseptic conditions. After making the
incision in the muscles, the testes were removed from the scrotal
sac with a curved sterile forceps through the incision by gently
pulling the dorsal fat pad associated with the testis. A solution of
lentiviruses resuspended in dPBS (Invitrogen) containing trypan
blue (0.04%) was injected slowly into the inter-tubular space of one
testis using a 30 gauge needle. The untransduced testis was
vasectomised. The animals were kept on thermal plate until they
recovered from the surgery to avoid hypothermia. The pre-
founder male mice were co-habitated with wild-type females 35
days post-transduction and the pups generated were analyzed for
the presence of the EGFP-f transgene.
The pre-founder male mice were mated with wild-type females
(ratio 1:2). Pups born were analyzed by PCR using genomic DNA
obtained from their tail tip and those positive for the transgene
were considered as F1 generation of transgenic animals. F2
generation of mice were produced either by breeding transgene
positive animals with wild-type Crl:CFW(SW) mice or by breeding
two mice positive for the presence of the transgene. The pups from
these matings were analyzed for the presence of the transgene as
described.
Isolation of Genomic DNA (gDNA)
Tail biopsies (,3 mm) from 3 weeks old pups sired by pre-
founder males were taken and lysed for 16 h at 55uC in high salt
digestion buffer containing 50 mM Tris HCl, 1% SDS, 100 mM
NaCl, 100 mM EDTA and 1200 mg/ml Proteinase K (Jackson
Laboratories). The lysate was processed for isolation of DNA using
phenol-chloroform extraction followed by ethanol precipitation.
Polymerase Chain Reactions and Reverse Transcriptase
PCR
The genomic DNA was subjected for PCR analysis using
transgene-specific primers (Table 3). Every PCR reaction set had
three controls. The pLKO.EGFP-f plasmid was used as a template
for a positive control, the genomic DNA obtained from WT
mice was used as a negative control and amplification of the
endogenous patch gene was used as a loading control. RNA was
prepared from tissues using the Qiagen RNeasy kit as per the
manufacturers protocol and RT-PCR was conducted using
RevertAid
TM First Strand cDNA synthesis Kit (NEB) according
to manufacturer’s protocol.
Fluorescence and Immunofluorescence microscopy
5 mm cryosections of multiple tissues were observed by confocal
microscopy to detect the presence of EGFP-f. Confocal images
were obtained by using a LSM 510 Meta Carl Zeiss Confocal
system with an Argon 488 nm and Helium/Neon 543 nm lasers.
All images were obtained using an Axio Observer Z.1 microscope
(numerical aperture [NA] 1.4) at a magnification of 663. 5 mm
cryosections of testis were deparafinzed and treated with 1%
sodium borohydrate at room temperature to reduce auto-
fluoresence of tissues. Blocking was performed with 1%BSA and
tissues were further immunostained using GFP monoclonal
antibody 1:50 (clonetech) overnight to detect the presence of
Table 3. List of oligonucleotides used for PCR reactions.
Name of
oligonucleotide Sequence
EF1a Forward AAGCTTGGAATTGGCTCCGGTGCCCGTC
EF1a Reverse GAATTCCCTCACGACACCTGAAATGG
EGFP-f Forward GAATTCCACCATGGTGAGCAAG
EGFP-f Reverse GGATCCCCTCAGGAGAGCACACACTT
PolyA Forward GGATCCCCATACCACATTTGTAGAGG
PolyA Reverse GCGGCCGCATCGATACATTGATGAGTTTGGACAAACCAC
Ptch Forward CTGCGGCAAGTTTTTGGTTG
Ptch Reverse AGGGCTTCTCGTTGGCTACAAG
IPCR A CGGCGCGCCCTGCTGAGC
IPCR B GGCCACCGTCGGCGTCTCGCCCG
GAPDH Forward GGCTGCCCAGAACATCAT
GAPDH Reverse CGGACACATTGGGGGTAG
doi:10.1371/journal.pone.0021975.t003
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with the secondary antibody (Goat Anti mouse Alexa fluor 568
1:200 Invitrogen). Prpodium iodide was used to stain sperm DNA.
Confocal images were obtained as above. The image was further
analyzed using LSM 510 image browser and pseudoclour (green)
was used for representing the EGFP-f expression.
Inverse PCR and mapping of integration sites
Lentiviral integration sites were identified by modifying the
ligation-mediated PCR method as described in Figure 2D [15]. In
brief, 5 mg genomic DNA was digested with EcoRI for 4 h and
purified using the Qia-Quick PCR purification kit (Qiagen). The
purified DNA was then self-ligated with T4 ligase (NEB) at 4uC
overnight. The circular DNA was amplified using a specific primer
pair (Table 3). The amplified products were cloned into the
pJet1.2/Blunt vector (Fermentas) followed by sequencing on a
3100 Avant Genetic Analyser. The nucleotide sequences were
aligned and examined to confirm the presence of the expected
known transgene sequence and to identify the flanking sequence
which would be derived from the site of insertion. These flanking
sequences were matched with the mouse genome using a
stringency of .90% over at least 100 bp. The insertion site
sequence was analyzed using the Basic Local Alignment Search
Tool (BLAST) to determine the chromosomal location of the
transgene.
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